- What's the Analyst Recommendation for Baudax Bio Inc. (BXRX)?
- Let’s Take a Look at Plantronics Inc. (PLT) Stock
- Is it Time to Sell/Buy Isoray Inc. (ISR) Stock After Recent Trade?
- Avis Budget Group Inc. (CAR) is up 12.41% this year
- Code Chain New Continent Limited (CCNC) Stock Price Stood at $1.87 on Tuesday, October 20, What You Think?
RBC Capital Mkts announced it was Reiterated coverage of Neos Therapeutics Inc. in a research note on August 09, 2017. The analysts assigned an Outperform rating to the stock with a price target of $12. Cantor Fitzgerald rated the stock as an Overweight in a research noted published on August 01, 2017. UBS rated the stock as a Neutral in a research note published on March 20, 2017.
NEOS Recent Trade
The share price of NEOS ascended by $0.01 during the exchanging session on 07/13/20 to exchange at $0.65. Neos Therapeutics Inc. stock has an exchanging volume of 0.18 million shares, which is low, contrasted with its 3-months average volume of 184.47K shares. Its market capitalization has now reached to $33.82M.
NEOS Past Trading Activity
The market tends to become urbane often, in any event, for prepared investors and traders. In any event, when a merchant got what he/she had expected, the market occasionally chooses to move the other way. This instability leads a few traders questioning and re-thinking their moves. This is the reason becoming acquainted with past price performance, just as both long and short time period, is significant. If we look the past performance, during the last one week, NEOS price has dropped by -8.35%. In the course of past three months sees the stock go down around -27.79%, while it has lost -52.90% over the past six months and -56.95% since the start of the year.
NEOS Earning History
Earnings per share are the amount of profit that a company produces during a specific period, which is usually defined as a quarter (three calendar months) or a year. In recent quarter of (Jun 2020), the firm recorded a revenue of 14.49 billion, which was higher than the gauge of 12.17M made by certain experts. For that equivalent quarter, Neos Therapeutics Inc. posted -$0.16 earnings per share (EPS) which was underneath the consensus estimate of -$0.09 by -$0.07, which represents to a reduction by -77.80%.
NEOS Price Performance
Let us presently take a gander at a portion of its probable help and opposition resistance. Late research on Neos Therapeutics Inc. has seen its stock exchanging -38.68% underneath its three-month high price. A glance at the opposite side additionally observes stock exchanging +2.52% above its three-month low. A more extensive look sees NEOS exchanging -69.77% beneath its 52-week high and 8.33% above from its 52-week low price.
NEOS Instability & Beta Factor
The Volatility of a stock means that the stock’s drop or increase in the event that the more extensive market drops or rushes. A beta score higher than 1 implies that a stock is profoundly unpredictable while underneath 1 implies that the Volatility of a stock is low. If we look trading Volatility. Its 7-day Volatility is around 6.47%, while it has a month to month instability of 7.78%. The company has an ATR (Average True Range) of 0.06 and a beta factor of 1.27.